These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
515 related articles for article (PubMed ID: 24892704)
1. Membranous nephropathy: from models to man. Beck LH; Salant DJ J Clin Invest; 2014 Jun; 124(6):2307-14. PubMed ID: 24892704 [TBL] [Abstract][Full Text] [Related]
2. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy. Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555 [TBL] [Abstract][Full Text] [Related]
3. Circulating antibodies to α-enolase and phospholipase A Kimura Y; Miura N; Debiec H; Morita H; Yamada H; Banno S; Ronco P; Imai H Clin Exp Nephrol; 2017 Feb; 21(1):117-126. PubMed ID: 26830547 [TBL] [Abstract][Full Text] [Related]
4. Thrombotic thrombocytopenic purpura developed during the conservative treatment of anti-phospholipase A Iio R; Akiyama S; Mitsumoto K; Iwata Y; Okushima H; Shimada K; Ota N; Tomida K; Fushimi H; Shoji T; Matsumoto M; Hayashi T BMC Nephrol; 2020 Oct; 21(1):431. PubMed ID: 33046023 [TBL] [Abstract][Full Text] [Related]
5. [Anti-NEP and anti-PLA2R antibodies in membranous nephropathy: an update]. Pozdzik AA; Debiec H; I Brochériou ; Husson C; Rorive S; Broeders N; Le Moine A; Ronco P; Nortier J Rev Med Brux; 2015; 36(3):166-71. PubMed ID: 26372979 [TBL] [Abstract][Full Text] [Related]
6. Membranous Nephropathy: A Journey From Bench to Bedside. Francis JM; Beck LH; Salant DJ Am J Kidney Dis; 2016 Jul; 68(1):138-47. PubMed ID: 27085376 [TBL] [Abstract][Full Text] [Related]
7. Immunology of membranous nephropathy: from animal models to humans. Sinico RA; Mezzina N; Trezzi B; Ghiggeri GM; Radice A Clin Exp Immunol; 2016 Feb; 183(2):157-65. PubMed ID: 26459770 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases. Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027 [TBL] [Abstract][Full Text] [Related]
9. Management of Membranous Nephropathy in the PLA Bomback AS Clin J Am Soc Nephrol; 2018 May; 13(5):784-786. PubMed ID: 29378770 [No Abstract] [Full Text] [Related]
10. PLA2R and THSD7A: Disparate Paths to the Same Disease? Beck LH J Am Soc Nephrol; 2017 Sep; 28(9):2579-2589. PubMed ID: 28674044 [TBL] [Abstract][Full Text] [Related]
11. A Novel Insight into the Role of PLA2R and THSD7A in Membranous Nephropathy. Zhang P; Huang W; Zheng Q; Tang J; Dong Z; Jiang Y; Liu Y; Liu W J Immunol Res; 2021; 2021():8163298. PubMed ID: 34337081 [TBL] [Abstract][Full Text] [Related]
12. Retrospective Study of Phospholipase A2 Receptor and IgG Subclasses in Glomerular Deposits in Chinese Patients with Membranous Nephropathy. Dong HR; Wang YY; Cheng XH; Wang GQ; Sun LJ; Cheng H; Chen YP PLoS One; 2016; 11(5):e0156263. PubMed ID: 27223897 [TBL] [Abstract][Full Text] [Related]
13. The pathogenesis of membranous nephropathy: evolution and revolution. Glassock RJ Curr Opin Nephrol Hypertens; 2012 May; 21(3):235-42. PubMed ID: 22388552 [TBL] [Abstract][Full Text] [Related]
14. Characterization of autoantibodies in primary membranous nephropathy and their clinical significance. Stahl RA; Reinhard L; Hoxha E Expert Rev Clin Immunol; 2019 Feb; 15(2):165-175. PubMed ID: 30433832 [No Abstract] [Full Text] [Related]
15. Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor. Jatem Escalante E; Segarra Medrano A; Carnicer Cáceres C; Martín-Gómez MA; Salcedo Allende MT; Ostos Roldan H; Agraz Pamplona I Nefrologia; 2015; 35(5):479-86. PubMed ID: 26306972 [TBL] [Abstract][Full Text] [Related]
16. Autoantibodies specific for the phospholipase A2 receptor in recurrent and De Novo membranous nephropathy. Debiec H; Martin L; Jouanneau C; Dautin G; Mesnard L; Rondeau E; Mousson C; Ronco P Am J Transplant; 2011 Oct; 11(10):2144-52. PubMed ID: 21827616 [TBL] [Abstract][Full Text] [Related]
18. PLA2R antibodies and PLA2R glomerular deposits in psoriasis patients with membranous nephropathy. Ge YC; Jin B; Zeng CH; Zhang MC; Chen DC; Yin R; Le WB BMC Nephrol; 2016 Nov; 17(1):185. PubMed ID: 27876003 [TBL] [Abstract][Full Text] [Related]
19. The fate of immune complexes in membranous nephropathy. Xu J; Hu H; Sun Y; Zhao Z; Zhang D; Yang L; Lu Q Front Immunol; 2024; 15():1441017. PubMed ID: 39185424 [TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]